Gilead CFO granted 11,090 performance shares

Gilead Sciences Chief Financial Officer Andrew D. Dickinson acquired 11,090 shares of common stock through a grant/award on performance share units.

Rhea-AI Filing Summary

Gilead Sciences Chief Financial Officer Andrew D. Dickinson acquired 11,090 shares of common stock through a grant/award on performance share units. These shares vested after both performance and service conditions were met, bringing his directly held total to 178,869 shares of Gilead common stock.

Insider Trade Summary

Grant/Award: 11,090 shares

Grant/Award 1 txn

Insider Dickinson Andrew D

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,090	$0.00	$0.00

Holdings After Transaction: Common Stock — 178,869 shares (Direct)

Footnotes (1)

1. F1. Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Gilead Sciences (GILD) CFO Andrew Dickinson report on this Form 4?

Andrew Dickinson reported acquiring 11,090 shares of Gilead common stock through a grant or award. The shares relate to performance share awards that vested after meeting performance and service conditions, increasing his directly held stake to 178,869 shares.

How many Gilead (GILD) shares did the CFO acquire in this transaction?

The CFO acquired 11,090 shares of Gilead common stock at a stated price of $0.00 per share. These shares came from previously granted performance share awards that vested once performance goals were certified and service requirements were satisfied.

What type of equity award did Gilead (GILD) use in this CFO transaction?

The transaction involves tranches of performance share awards granted on March 10, 2025. These awards carried both performance-vesting and service-vesting requirements, and the reported shares became deliverable once the Compensation and Talent Committee certified goal attainment.

How many Gilead (GILD) shares does the CFO hold after this Form 4 event?

After this award-related acquisition, the CFO directly holds 178,869 shares of Gilead common stock. This total reflects the addition of 11,090 vested performance shares that satisfied required performance metrics and ongoing service terms.

Were the Gilead (GILD) CFO’s new shares purchased on the open market?

No, the 11,090 shares were not open-market purchases. They represent common stock delivered under performance share awards that vested after the Compensation and Talent Committee certified achievement of performance goals and service conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/02/2026 - 04:57 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dickinson Andrew D

(Last) (First) (Middle)

GILEAD SCIENCES, INC.

333 LAKESIDE DRIVE

(Street)

FOSTER CITY CA 94404

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
GILEAD SCIENCES, INC. [ GILD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		11,090	A(1)	$0	178,869	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors.

Remarks:

	/s/ Edward S. Son by Power of Attorney for Andrew D. Dickinson	03/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.